Visit Aktiedagen Lund September 26, and learn how ultrasound can be used to fight the world’s deadliest diseases
Monday September 26, 6.30-7.00 pm (18:30-19:00)
Elite Hotel Ideon, Scheelevägen 27
At Aktiedagen Lund on Monday 26 September 2022, AcouSort’s Commercial Director Agnes Michanek will talk about how AcouSort's unique and validated ultrasound technology can be used in the fight against cardiovascular diseases, infections, and cancer – the three deadliest diseases in the world. AcouSort is at a very exciting stage in the company's development with a growing interest in its technology from several life science companies. The presentation will be held in Swedish.
Further information: https://www.aktiespararna.se/aktiviteter/aktiedagen-lund-1
Aktiespararna will stream live and on demand via Aktiespararna's YouTube channel and via aktiespararna.se
For further information on AcouSort, please contact:
Torsten Freltoft, CEO
Telephone: +45 2045 0854
E-mail: torsten.freltoft@acousort.com
About AcouSort
AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify and stain cells, exosomes and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing – so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company’s Certified Adviser is Erik Penser Bank, 08-463 83 00, mail to: certifiedadviser@penser.se Erik Penser Bank AB (publ), Apelbergsgatan 27, Box 7405, 103 91 Stockholm.